Literature DB >> 12186218

Completely resistant Acinetobacter baumannii strains.

Siham Mahgoub1, Jimi Ahmed, Aaron E Glatt.   

Abstract

Nosocomially acquired completely resistant Acinetobacter baumannii strains are a major clinical concern. We identified completely resistant A. baumannii in 6 (4.9%) of 122 A. baumannii isolates in a retrospective chart review at two teaching hospitals. All of these patients had received broad-spectrum antibiotics and had severe underlying comorbid illnesses, long hospitalizations, or recent surgical procedures; 3 had been in the intensive care unit. Five (83%) of the 6 patients were older than 70 years. Only one death occurred. Strict infection control measures may limit further spread.

Entities:  

Mesh：

Year:  2002        PMID： 12186218     DOI： 10.1086/502091

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center.

Authors:  D G Dauner; J R May; J C H Steele
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-10       Impact factor: 3.267

2.  Pan-PCR, a computational method for designing bacterium-typing assays based on whole-genome sequence data.

Authors:  Joy Y Yang; Shelise Brooks; Jennifer A Meyer; Robert R Blakesley; Adrian M Zelazny; Julia A Segre; Evan S Snitkin
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

3.  Pharmacodynamics modeling to optimize dosage regimens of sulbactam.

Authors:  Sutep Jaruratanasirikul; Wibul Wongpoowarak; Nanchanit Aeinlang; Monchana Jullangkoon
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

4.  Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii.

Authors:  Evan S Snitkin; Adrian M Zelazny; Clemente I Montero; Frida Stock; Lilia Mijares; Patrick R Murray; Julie A Segre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

5.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii.

Authors:  Sutep Jaruratanasirikul; Wibul Wongpoowarak; Thitima Wattanavijitkul; Waroonrat Sukarnjanaset; Maseetoh Samaeng; Monchana Nawakitrangsan; Natnicha Ingviya
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  The rising problem of antimicrobial resistance in the intensive care unit.

Authors:  Nele Brusselaers; Dirk Vogelaers; Stijn Blot
Journal:  Ann Intensive Care       Date:  2011-11-23       Impact factor: 6.925

9.  Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran.

Authors:  S Japoni; S Farshad; A Abdi Ali; A Japoni
Journal:  Iran Red Crescent Med J       Date:  2011-11-01       Impact factor: 0.611

10.  Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.

Authors:  Hua Zhou; Yake Yao; Bingquan Zhu; Danhong Ren; Qing Yang; Yiqi Fu; Yunsong Yu; Jianying Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.